RxDoctor Payments DataLook up a doctor →

Kaitlin Cores, MD

Psychiatry · Tulsa, OKNPI 1558518050

Payments from drug & device makers

$9,671in general payments, 2019–2025

Across 636 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Corium, LLC$991
  • AbbVie$944
  • Alkermes, Inc.$912
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$872
  • Sunovion Pharmaceuticals Inc.$782
  • plus $4K from 25 others

What the payments were for

  • Food & beverage$9,62299%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,671 in reported general payments places this provider in the 90th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$97,288
Medicare patients
250
Services billed
979

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl67$98,775
TrintellixVortioxetine Hydrobromide47$27,429
Risperdal ConstaRisperidone Microspheres14$26,669
RexultiBrexpiprazole17$25,338
Clozapine184$14,962
Chlorpromazine Hcl47$11,014
Lurasidone Hcl83$10,146
Aripiprazole238$9,257
Quetiapine Fumarate441$8,365
Clozapine OdtClozapine26$8,200
Duloxetine Hcl192$7,820
Bupropion XlBupropion Hcl239$6,995
Venlafaxine Hcl ErVenlafaxine Hcl277$6,281
Olanzapine258$6,002
Buspirone Hcl188$5,971

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$944$98,77567 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$134$27,42947 claims
Johnson & JohnsonRisperdal Consta$1,065$26,66914 claims
Otsuka America Pharmaceutical, Inc.Rexulti$545$25,33817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 328 psychiatry providers in Oklahoma.

Other psychiatry in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →